| Literature DB >> 31391188 |
Hueiming Liu1,2,3, Alim Mohammed4, Janani Shanthosh2,3, Madeline News2,3, Tracey-Lea Laba2,3,5, Maree L Hackett1,2,3, David Peiris2,3, Stephen Jan1,2,3.
Abstract
OBJECTIVE: Process evaluations (PEs) alongside randomised controlled trials of complex interventions are valuable because they address questions of for whom, how and why interventions had an impact. We synthesised the methods used in PEs of primary care interventions, and their main findings on implementation barriers and facilitators.Entities:
Keywords: non-communicable disease; primary care; process evaluations; qualitative research; systematic review
Mesh:
Year: 2019 PMID: 31391188 PMCID: PMC6687007 DOI: 10.1136/bmjopen-2018-025127
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1PRISMA figure. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RCT, randomised controlled trial.
Summary of the characteristics of the included studies
| Disease condition | Interventions | Setting | RCT outcomes | Cost considerations (Y/N/NA) |
| 20 studies on depression. | Interventions mostly around collaborative care through increasing expertise of different roles (eg, lay worker, nurse for proactive care, GP for PHC) (16 studies), times to implement practice guidelines (4 studies), and trialling specific interventions such as physical exercise and cognitive–behavioural therapy (2 studies). | 9 UK. | 11 Positive. | 4 Y. |
| 17 studies on diabetes. | The interventions included improving guideline-based referral and treatment (7 studies), patient self-management, community support (7 studies) and telehealth (3 studies). | 4 Ireland. | 6 Positive. | 3Y. |
| 25 studies on CVD. | 10 studies were about improving the screening and management of CVD using best-practice guidelines (eg, educational materials to improve referral or decision analysis). 10 studies were about organisational change with models of care that incorporated new roles such as a nurse-led clinic, or the use of a lay worker for angina management, and technology (eg, telemonitoring, point of care testing). 5 studies explored trial implementation such as recruitment of patients and providers, and were less about the intervention. | 9 UK. | 15 Positive. | 3 Y. |
| 6 studies on COPD (2 including other chronic disease) and 1 addressing CKD. | 4 studies were about improving self-management of patients through educational materials, or use of monitoring, with support from health providers. 2 studies were about stimulating physical activity through the use of technology. 1 study was about implementing management guidelines in CKD in PHC. | 3 The Netherlands. | 2 Positive. | 0 Y. |
| Overall synthesis of 69 studies in total. | Overall, the complex primary care interventions fit within the general categories of facilitating patient self-management (13 studies), organisational change to include collaborative care (16 studies), facilitating better case management using clinical information systems (eg, telehealth) (15 studies), and the use of decision support and guideline implementation (eg, referral systems) (22 studies). In addition, 5 studies were exploring the conduct of trials in PHC, for example, the recruitment of patients. | 22 UK. | 34 Positive. | 10 Y*. |
*Of note two were full evaluation reports (outcome, process and economic evaluations) in the UK journal of Health Technology Assessments in addressing the question of whether an innovation with limited evidence base in a pragmatic setting (eg, introducing cognitive–behavioural therapy in schools) should be scaled up. Eight papers included descriptions of how cost considerations such as financing incentives/government subsidies impacted on intervention implementation.
CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; CVD, cardiovascular disease; GP, general practices; N, no; NA, not applicable; PHC, primary healthcare; RCT, randomised controlled trial; Y, yes.
Figure 2Medical Research Council process evaluation framework with tallies of studies, methods and synthesised findings. N/A, not applicable; RCT, randomised controlled trial.
Summary of the methodology used and quality assessment of the studies
| Stage of process evaluation | Methodology and methods | Analysis | Quality criteria |
| Feasibility/Piloting, 20 studies. | 9 studies used theories or frameworks. 18 used interviews. 3 used focus group discussions, 4 used questionnaires or surveys, 2 studies used routine monitoring data, field notes, minutes of meetings and observations. | Thematic analysis, constant comparative approach most commonly used, with some using framework analysis. |
|
| Evaluation of effectiveness, 43 studies. | 12 studies used existing theories and frameworks (6 classic theories, | Descriptive statistics were used for the quantitative data, and thematic, constant comparison and framework analysis for the qualitative data. |
|
| Post-evaluation, 6 studies | 1 study used existing theory. 2 studies used interviews, 2 used documentary analysis, and 1 used the administrative data and registry data. | Descriptive statistics, subgroup analysis and thematic analysis. |
|
COREQ, Consolidated criteria for Reporting Qualitative research; N, no; NA, not applicable; NPT, normalisation process theory; RE-AIM, reach, efficacy/effectiveness, adoption, implementation and maintenance framework; Y, yes.